Updated Sep 2, 2026
/Trump and Rubio seal Venezuela oil deal covering 65 billion barrels across 17 fields/Bond rout gathers pace as borrowing costs hit multi-decade highs/Van Jones calls El-Sayed's total Israel arms embargo 'insane,' cites Obama legacy on defense/Memecoin buys on Robinhood Wallet and Fomo coded as "digital media," sidestepping card-network crypto rules/Caring Brands (CABR) Closes $4.6 Million Initial Series B Preferred Stock Private Placement/Sanmar Group takes majority stake in AltEons Energy to back 1.5GW India pipeline/Trump and Rubio seal Venezuela oil deal covering 65 billion barrels across 17 fields/Bond rout gathers pace as borrowing costs hit multi-decade highs/Van Jones calls El-Sayed's total Israel arms embargo 'insane,' cites Obama legacy on defense/Memecoin buys on Robinhood Wallet and Fomo coded as "digital media," sidestepping card-network crypto rules/Caring Brands (CABR) Closes $4.6 Million Initial Series B Preferred Stock Private Placement/Sanmar Group takes majority stake in AltEons Energy to back 1.5GW India pipeline

Glancy Prongay Wolke & Rotter Continues Securities Fraud Probe Into GE HealthCare Technologies

LOS ANGELES, July 8. Glancy Prongay Wolke & Rotter LLP said it is continuing a securities fraud investigation into GE HealthCare Technologies Inc. (NASDAQ: GEHC) on behalf of the company's investors, urging shareholders who reported losses to contact the firm.

By Julian Merrick2 min read
Share

Key takeaways

  • Glancy Prongay Wolke & Rotter LLP announced on July 8 that it is continuing a securities fraud investigation into GE HealthCare Technologies Inc. (NASDAQ: GEHC) on behalf of the company's investors.
  • The firm's use of the word 'continues' indicates the investigation predates the July 8 announcement.
  • No specific conduct, timeframe, or nature of the alleged violations was disclosed, and no findings of wrongdoing have been established.
  • No court filings were disclosed and no deadline was set for investors to come forward.
  • GE HealthCare investors who sustained losses are being urged to contact the Los Angeles-based firm directly.

LOS ANGELES, July 8. Glancy Prongay Wolke & Rotter LLP said it is continuing a securities fraud investigation into GE HealthCare Technologies Inc. (NASDAQ: GEHC) on behalf of the company's investors, urging shareholders who reported losses to contact the firm.

Investigation status

The Los Angeles firm described itself in the release as a leading national shareholder rights law firm. The probe is being conducted on behalf of GE HealthCare investors, the release said. No specific conduct was identified, no timeframe was given, and the nature of the alleged violations was not disclosed.

The firm's use of "continues" signals the investigation predates the July 8 announcement. No court filings were disclosed and no findings of wrongdoing have been established.

What shareholders are being asked to do

Investors in GE HealthCare Technologies who sustained losses are being urged to reach out to Glancy Prongay Wolke & Rotter directly, according to the release. The firm set no deadline for investors to come forward and disclosed no count of those who have already made contact.

GE HealthCare Technologies Inc. trades on the Nasdaq under the ticker GEHC.


Frequently asked

Which company is being investigated and under what ticker does it trade?

GE HealthCare Technologies Inc. is being investigated; it trades on the Nasdaq under the ticker GEHC.

What are shareholders being asked to do?

Investors in GE HealthCare Technologies who sustained losses are being urged to contact Glancy Prongay Wolke & Rotter directly, with no deadline set for coming forward.

Has any wrongdoing been proven against GE HealthCare?

No findings of wrongdoing have been established, no court filings were disclosed, and the nature of the alleged violations was not identified.

When was the investigation announced?

The announcement was made on July 8, though the firm's use of 'continues' signals the investigation predates that date.